Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Orvosi Hetilap|August 2, 2005
[Electrogastrography monitoring of the effectiveness of prokinetic and cognitive therapy in functional dyspepsia]Györgyi Fodor, Richárd Schwab, Tibor Gyökeres, et al.Orvosi Hetilap|February 27, 2018
[Review of the relation between gut microbiome, metabolic disease and hypertension]István Barna, Dóra Nyúl, Tamás Szentes, et al.Nature Reviews. Drug Discovery|June 10, 2010
Integrating molecular diagnostics into anticancer drug discoveryIstván Peták, Richárd Schwab, László Orfi, et al.Orvosi Hetilap|June 5, 2002
[Extracorporeal shock wave lithotripsy of pancreatic stones as a part of complex endoscopic therapy]Tibor Gyökeres, Richárd Schwab, Mária Burai, et al.Cancer Detection and Prevention|April 3, 2003
The antitumour effect of the somatostatin analogue TT-232 depends on the treatment regimenMiguel Tejeda, Dezsõ Gaál, Orsolya Csuka, et al.Journal of Receptor and Signal Transduction Research|January 6, 2006
TT232, a novel signal transduction inhibitory compound in the therapy of cancer and inflammatory diseasesOrsolya Szokolóczi, Richárd Schwab, István Peták, et al.Head & Face Medicine|October 20, 2007
Malignant fibrous histiocytoma of the face: report of a caseLászló Seper, Richárd Schwab, Sirichai Kiattavorncharoen, et al.Plos One|September 29, 2017
Molecular subtype specific efficacy of MEK inhibitors in pancreatic cancersDiána Brauswetter, Bianka Gurbi, Attila Varga, et al.Orvosi Hetilap|December 24, 2005
[Epidermal growth factor receptor (EGFR): therapeutic target in the treatment of lung adenocarcinoma]Richárd Schwab, István Peták, Ferenc Pintér, et al.Pageof 1